Go to navigation
Go to content
Astrazeneca Worldwide
AstraZeneca Websites
Search
Main navigation
Home
Therapy Areas
Oncology/Infection
Cardiovascular
Gastrointestinal
Neuroscience
Respiratory/Inflammation
Drug Products
All Drug Products
Diseases & Conditions
All Diseases and Conditions
Glossary
Contact Us
Disclosure Commitment
You are here
Home
Drug Products
All Drug Products
Perceived hypoglycemia- and weight-related Quality of Life of patients with sulfonylurea derivate-treated Diabetes Mellitus Type 2, a non-interventional study.
Disease
diabetes type 2
Drug Name
non drug study (cardiovascular)
Generic Name
No Drug
Sponsor
AstraZeneca
Drug Status
Non-Drug
Phase
Non-Interventional Study
Start Date
Dec 3, 2010
Study Name
NIS-CNL-DUM-2010/1
Study Id
NIS-CNL-DUM-2010/1
ClinicalTrials.gov ID
NCT01244646
Recruiting Status
Closed
Protocol Status
Not Available
Report
Dec 1, 2012
NIS-CNL-DUM-2010/1.pdf
(132 KB)
Page tools
Print
Bookmark this page